Examining the role of cyclin D1 in breast cancer

By Velasco-Veláázquez Marco A   Li Zhiping   Casimiro Mathew   Loro Emanuele   Homsi Nora   Pestell Richard G  

Future Oncology, Vol. 7, Iss. 6, 2011-06 ,pp. : 753-765

Future Medicine

Access to resources Recommend Favorite

Efficient downregulation of ErbB-2 induces TACC1 upregulation in breast cancer cell lines

By Xiang Jinyu   Qiu Wensheng   Wang Xingang   Zhou Fang   Wang Zhen   Liu Shihai   Yue Lu  

Oncology Reports, Vol. 29, Iss. 4, 2013-04 ,pp. : 1517-1523

Spandidos Publications

Access to resources Recommend Favorite

ErbB-2 protein in sera and tumors of breast cancer patients

By Breuer Brenda   Smith Steven   Thor Ann   Edgerton Susan   Osborne Michael P.   Minick Richard   Cody   III Hiram S.   Nowak Eugene   Cortese Armand   Simmons Rache M.   Carney Walter P.   Brandt-Rauf Paul W.  

Breast Cancer Research and Treatment, Vol. 49, Iss. 3, 1998-06 ,pp. : 261-270

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of the AKT/mTOR and erbB pathways by gefitinib, perifosine and analogs of gonadotropin-releasing hormone I and II to overcome tamoxifen resistance in breast cancer cells

By                  

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1845-1854

Spandidos Publications

Access to resources Recommend Favorite

Direct binding of Copine3 with Jab1 activates downstream ErbB2 signaling and motility in SKBr3 breast cancer cells

By            

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 1147-1152

Spandidos Publications

Access to resources Recommend Favorite